Development of innovative granules based on chitosan with the addition of unique biomodifiers, intended for processing with extrusion technique. (Q4420224): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Changed label, description and/or aliases in en, and other parts) |
||||||||||||||
| label / en | label / en | ||||||||||||||
Development of innovative granules based on chitosan with the addition of unique biomodifiers, intended for processing with extrusion technique. | |||||||||||||||
| Property / summary | |||||||||||||||
Number_reference_aid_programme: SA.41471(2015/X) Purpose of public aid: art: 25 EC Regulation No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Articles 107 and 108 of the Treaty (OJ L 119, p. That’s it. EU L 187/1 of 26.06.2014).The aim of the project is to develop at least one recipe and processing conditions for new, biodegradable, stable, homogeneous plasticised chitosan granules and/or composite with chitosan intended to be launched on the Polish market. The production of unique derivatives of natural polymer suitable for processing with techniques used for thermoplastic plastics will increase the scope of applications of these polymers on an industrial scale. The product developed, as a result of thermomechanical processing, will have a significantly expanded/different usability compared to the product currently obtained by wet processing. This will be achieved by using unique modifiers based on natural raw materials to plasticise the polymer. These modifiers will be designed and synthesised from available components, mainly from renewable sources. An optimal chemical structure of the biomodifiers used will be established, allowing to obtain a material based on chitosan with good processing and performance properties. The laboratory-based processing parameters of chitosan materials will be verified and optimised on a large-laboratory scale, and then on a technical quarter scale using a dedicated pilot line developed for this purpose. Based on the analysis of literature, patent databases and competitive environment, it was concluded that there are no solutions with the characteristics of a new product. The recipients of the product will be manufacturers of dressing products so-called: occlusive wounds intended for the treatment of medium haemorrhagic, pressure ulcers, inlet wounds, (English) | |||||||||||||||
| Property / summary: Number_reference_aid_programme: SA.41471(2015/X) Purpose of public aid: art: 25 EC Regulation No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Articles 107 and 108 of the Treaty (OJ L 119, p. That’s it. EU L 187/1 of 26.06.2014).The aim of the project is to develop at least one recipe and processing conditions for new, biodegradable, stable, homogeneous plasticised chitosan granules and/or composite with chitosan intended to be launched on the Polish market. The production of unique derivatives of natural polymer suitable for processing with techniques used for thermoplastic plastics will increase the scope of applications of these polymers on an industrial scale. The product developed, as a result of thermomechanical processing, will have a significantly expanded/different usability compared to the product currently obtained by wet processing. This will be achieved by using unique modifiers based on natural raw materials to plasticise the polymer. These modifiers will be designed and synthesised from available components, mainly from renewable sources. An optimal chemical structure of the biomodifiers used will be established, allowing to obtain a material based on chitosan with good processing and performance properties. The laboratory-based processing parameters of chitosan materials will be verified and optimised on a large-laboratory scale, and then on a technical quarter scale using a dedicated pilot line developed for this purpose. Based on the analysis of literature, patent databases and competitive environment, it was concluded that there are no solutions with the characteristics of a new product. The recipients of the product will be manufacturers of dressing products so-called: occlusive wounds intended for the treatment of medium haemorrhagic, pressure ulcers, inlet wounds, (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: Number_reference_aid_programme: SA.41471(2015/X) Purpose of public aid: art: 25 EC Regulation No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Articles 107 and 108 of the Treaty (OJ L 119, p. That’s it. EU L 187/1 of 26.06.2014).The aim of the project is to develop at least one recipe and processing conditions for new, biodegradable, stable, homogeneous plasticised chitosan granules and/or composite with chitosan intended to be launched on the Polish market. The production of unique derivatives of natural polymer suitable for processing with techniques used for thermoplastic plastics will increase the scope of applications of these polymers on an industrial scale. The product developed, as a result of thermomechanical processing, will have a significantly expanded/different usability compared to the product currently obtained by wet processing. This will be achieved by using unique modifiers based on natural raw materials to plasticise the polymer. These modifiers will be designed and synthesised from available components, mainly from renewable sources. An optimal chemical structure of the biomodifiers used will be established, allowing to obtain a material based on chitosan with good processing and performance properties. The laboratory-based processing parameters of chitosan materials will be verified and optimised on a large-laboratory scale, and then on a technical quarter scale using a dedicated pilot line developed for this purpose. Based on the analysis of literature, patent databases and competitive environment, it was concluded that there are no solutions with the characteristics of a new product. The recipients of the product will be manufacturers of dressing products so-called: occlusive wounds intended for the treatment of medium haemorrhagic, pressure ulcers, inlet wounds, (English) / qualifier | |||||||||||||||
point in time: 21 October 2022
| |||||||||||||||
Revision as of 12:33, 21 October 2022
Project Q4420224 in Poland
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of innovative granules based on chitosan with the addition of unique biomodifiers, intended for processing with extrusion technique. |
Project Q4420224 in Poland |
Statements
2,851,024.32 zloty
0 references
633,782.71 Euro
0 references
3,816,093.69 zloty
0 references
848,317.63 Euro
0 references
74.71 percent
0 references
1 November 2020
0 references
31 December 2023
0 references
SIEĆ BADAWCZA ŁUKASIEWICZ- ŁÓDZKI INSTYTUT TECHNOLOGICZNY
0 references
Numer_referencyjny_programu_pomocowego: SA.41471(2015/X) Przeznaczenie_pomocy_publicznej: art: 25 rozporządzenia KE nr 651/2014 z dnia 17 czerwca 2014 r. uznające niektóre rodzaje pomocy za zgodne z rynkiem wewnętrznym w stosowaniu art. 107 i 108 Traktatu (Dz. Urz. UE L 187/1 z 26.06.2014).Celem projektu jest opracowanie co najmniej jednej receptury i warunków przetwórstwa nowego, biodegradowalnego, stabilnego, homogenicznego granulatu chitozanu plastyfikowanego i/lub kompozytu z udziałem chitozanu przeznaczonego do wprowadzenia na rynek polski. Wytworzenie unikalnych pochodnych polimeru naturalnego, nadającego się do przetwórstwa technikami stosowanymi dla tworzyw termoplastycznych pozwoli zwiększyć zakres aplikacji tych polimerów w skali przemysłowej. Opracowany produkt, w wyniku termomechanicznego przetwarzania, będzie się cechował znacząco poszerzoną/odmienną użytecznością względem produktu pozyskiwanego obecnie drogą przetwarzania metodą mokrą. Cel ten zostanie osiągnięty poprzez zastosowanie do uplastycznienia polimeru unikalnych modyfikatorów, opartych na surowcach naturalnych. Modyfikatory te zostaną zaprojektowane i zsyntezowane z dostępnych komponentów, głównie ze źródeł odnawialnych. Ustalona zostanie optymalna struktura chemiczna stosowanych biomodyfikatorów pozwalająca uzyskać materiał na bazie chitozanu o dobrych właściwościach przetwórczych i użytkowych. Ustalone w warunkach laboratoryjnych parametry przetwórstwa materiałów opartych o chitozan zostaną zweryfikowane i zoptymalizowane w skali wielkolaboratoryjnej, a następnie w skali ćwierć technicznej z wykorzystaniem dedykowanej do tego celu i opracowanej w ramach projektu linii pilotażowej. Na podstawie analizy literatury, baz patentowych, jak i otoczenia konkurencyjnego stwierdzono, że nie istnieją rozwiązania posiadające cechy nowego produktu. Odbiorcami wyrobu będą producenci wyrobów opatrunkowych tzw.: okluzyjnych, przeznaczonych do leczenia ran średniokrwotocznych, odleżynowych, wlotowych, (Polish)
0 references
Number_reference_aid_programme: SA.41471(2015/X) Purpose of public aid: art: 25 EC Regulation No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Articles 107 and 108 of the Treaty (OJ L 119, p. That’s it. EU L 187/1 of 26.06.2014).The aim of the project is to develop at least one recipe and processing conditions for new, biodegradable, stable, homogeneous plasticised chitosan granules and/or composite with chitosan intended to be launched on the Polish market. The production of unique derivatives of natural polymer suitable for processing with techniques used for thermoplastic plastics will increase the scope of applications of these polymers on an industrial scale. The product developed, as a result of thermomechanical processing, will have a significantly expanded/different usability compared to the product currently obtained by wet processing. This will be achieved by using unique modifiers based on natural raw materials to plasticise the polymer. These modifiers will be designed and synthesised from available components, mainly from renewable sources. An optimal chemical structure of the biomodifiers used will be established, allowing to obtain a material based on chitosan with good processing and performance properties. The laboratory-based processing parameters of chitosan materials will be verified and optimised on a large-laboratory scale, and then on a technical quarter scale using a dedicated pilot line developed for this purpose. Based on the analysis of literature, patent databases and competitive environment, it was concluded that there are no solutions with the characteristics of a new product. The recipients of the product will be manufacturers of dressing products so-called: occlusive wounds intended for the treatment of medium haemorrhagic, pressure ulcers, inlet wounds, (English)
21 October 2022
0 references
WOJ.: OPOLSKIE, POW.: kędzierzyńsko-kozielski
0 references
WOJ.: ŁÓDZKIE, POW.: Łódź
0 references
Identifiers
POIR.04.01.04-00-0041/20
0 references